tiprankstipranks
Trending News
More News >
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (DE:JIL)
:JIL
JIL
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H
RESEARCH TOOLSreports

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (JIL) Price & Analysis

Compare
0 Followers

JIL Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

JIL FAQ

What was Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price range in the past 12 months?
Currently, no data Available
What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap?
Currently, no data Available
When is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s earnings last quarter?
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H released its earnings results on Mar 31, 2025. The company reported $0.018 earnings per share for the quarter, beating the consensus estimate of N/A by $0.018.
    Is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H overvalued?
    According to Wall Street analysts Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
      Does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pay dividends?
      Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pays a Notavailable dividend of $0.03 which represents an annual dividend yield of N/A. See more information on Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H dividends here
        What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate?
        Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H have?
        Currently, no data Available
        What happened to Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price movement after its last earnings report?
        Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H reported an EPS of $0.018 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
          Which hedge fund is a major shareholder of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H?
          Currently, no hedge funds are holding shares in DE:JIL

          Company Description

          Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H

          Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.
          Similar Stocks
          Company
          Price & Change
          Follow
          Lee's Pharmaceutical Holdings Limited
          Fusen Pharmaceutical Co., Ltd.
          JBM (Healthcare) Ltd.
          Dawnrays Pharmaceutical Holdings Ltd.
          Zhongzhi Pharmaceutical Holdings Limited
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis